Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 1,750,043 5.900% | -86,502 (-4.71%) | Filing History |
| 2022-02-14 4:36 pm Unchanged | 2021-12-31 | 13G | ODONATE, INC. ODTC | Ikarian Capital, LLC | 0 3.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:35 pm Purchase | 2021-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital, LLC | 901,362 3.300% | 901,362 (New Position) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | SCIENCE 37 HLDGS INC SNCE | Ikarian Capital, LLC | 0 0.000% | -131,249 (Position Closed) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital, LLC | 28 1.000% | -83 (-74.77%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 496,756 5.900% | -3,244 (-0.65%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital, LLC | 36,576 0.200% | -1,027,385 (-96.56%) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital, LLC | 58,803 0.900% | -31,065 (-34.57%) | Filing History |
| 2022-02-14 4:30 pm Sale | 2021-12-31 | 13G | LYRA THERAPEUTICS INC LYRA | Ikarian Capital, LLC | 7,891 3.000% | -8,416 (-51.61%) | Filing History |
| 2021-09-17 3:00 pm Purchase | 2021-09-16 | 13G | ATYR PHARMA INC ATYR | Ikarian Capital, LLC | 888,580 5.300% | 888,580 (New Position) | Filing History |